Charles River Laboratories International, Inc. (CRL)

NYSE: CRL · Real-Time Price · USD

163.02

+0.77 (0.47%)

At close: Feb 21, 2025, 4:00 PM

165.15

+2.13 (1.31%)

After-hours: Feb 21, 2025, 7:24 PM EST

CRL Market Cap

CRL has a market cap or net worth of $8.34 billion as of February 21, 2025. Its market cap has decreased by -25.31% in one year.

Market Cap

8.34B

Enterprise Value

10.92B

1-Year Change

-25.31%

Ranking

#992

Market Cap Chart

Since June 23, 2000, CRL's market cap has increased from $226.30M to $8.34B, an increase of 3,584.09%. That is a compound annual growth rate of 15.74%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	8.30B	-12.10%
Dec 31, 2024	9.44B	-22.16%
Dec 29, 2023	12.13B	9.38%
Dec 30, 2022	11.09B	-41.69%
Dec 31, 2021	19.01B	52.98%
Dec 31, 2020	12.43B	66.59%
Dec 31, 2019	7.46B	37.05%
Dec 31, 2018	5.44B	5.01%
Dec 29, 2017	5.18B	43.75%
Dec 30, 2016	3.61B	-3.79%
Dec 31, 2015	3.75B	25.52%
Dec 31, 2014	2.99B	17.00%
Dec 31, 2013	2.55B	40.28%
Dec 31, 2012	1.82B	34.64%
Dec 30, 2011	1.35B	-34.13%
Dec 31, 2010	2.05B	-7.60%
Dec 31, 2009	2.22B	25.20%
Dec 31, 2008	1.77B	-60.32%
Dec 31, 2007	4.47B	54.46%
Dec 29, 2006	2.89B	-5.57%
Dec 30, 2005	3.06B	2.77%
Dec 31, 2004	2.98B	89.75%
Dec 31, 2003	1.57B	-9.52%
Dec 31, 2002	1.74B	17.55%
Dec 31, 2001	1.48B	50.25%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings